Top Markets
#1 Ontology Gas Ontology Gas +23.38%
#2 EXOD EXOD +22.08%
#3 Status Status +20.38%
#4 ETHGas ETHGas +14.18%
#5 aelf aelf +13.27%
#6 Fake World Assets Fake World Assets +10.63%
#7 The Black Bull The Black Bull +10.03%
#8 Derive Derive +8.64%
#9 Gas Gas +7.44%
#10 Meteora Meteora +6.38%
Coin of the day
Ontology Gas Ontology Gas
Settings
Language
ENGLISH
Currency
USD
Theme
Vicapsys Life Sciences, Inc. Vicapsys Life Sciences, Inc.

Vicapsys Life Sciences, Inc.

VICP
Rank in Stocks #25708
Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive... Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive VICAPSYN product to market, guiding it through development and commercialization. This product's intended application is within the field of transplantation, specifically for various transplant therapies and associated stem-cell uses. Additionally, the company is advancing the development of VYBRIN, a compound based on CXCL12. VYBRIN is being investigated for multiple purposes: preventing the formation of post-surgical adhesions following abdominal operations, coating implantable medical devices and other implants to inhibit fibrosis, and promoting wound healing, with a particular emphasis on diabetic ulcers. The firm, originally incorporated in 1997, transitioned its name from Phage Therapeutics International, Inc. to Vicapsys Life Sciences, Inc. in September 2017. Its operations are headquartered in Suwanee, Georgia.
Share Price
$1.45
Last synced: 2026-08-19
Market Cap
$46.94M
Change (1 day)
0.00%
Change (1 year)
-18.08%
Country
US
Trade Vicapsys Life Sciences, Inc. (VICP)

Category

Healthcare
Stock price history for Vicapsys Life Sciences, Inc. (VICP)
Highest end of day price: $1.45 on 2026-08-01

Lowest end of day price: $4.00K on 1998-02-01
Stock price history of Vicapsys Life Sciences, Inc. from 1998 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 1.38%
2025 -14.29%
2024 154.87%
2023 174.65%
2022 -50.00%
2021 33.33%
2020 0.00%
2019 -55.29%
2018 -6.80%
2017 -28.00%
2016 3,025.00%
2015 0.00%
2014 22.18%
2013 -67.67%
2012 -34.58%
2011 -94.15%
2010 -77.91%
2009 -6.88%
2008 -58.50%
2007 926.57%
2006 -33.53%
2005 -50.30%
2004 -58.93%
2003 -84.01%
2002 -89.45%
2001 44.98%
2000 27.56%
1999 44.30%
1998 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $119.20 -17.89%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 8.65%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US